| A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis (NCT01742585) | Astellas Pharma Inc | 2012-10-01 |
| Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients (NCT01809730) | NYU Langone Health | 2012-05-01 |
| Biomarkers Correlation With Volemia (NCT01858675) | ThermoFisher Scientific Brahms Biomarkers France | 2012-03-01 |
| Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067) (NCT01512667) | Merck Sharp & Dohme LLC | 2012-01-17 |
| Product Surveillance Registry (NCT01524276) | Medtronic | 2012-01-01 |
| Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney (NCT02355704) | Instituto Mexicano del Seguro Social | 2012-01-01 |
| Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency (NCT01337752) | Novartis Pharmaceuticals | 2012-01-01 |
| Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655) (NCT01432535) | Merck Sharp & Dohme LLC | 2011-11-01 |
| Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction (NCT01453218) | Hospital Vall d'Hebron | 2011-10-01 |
| A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency (NCT01407874) | BioCryst Pharmaceuticals | 2011-09-01 |
| PK Study of ACHN-490 Injection in Renally Impaired Subjects (NCT01462136) | Achaogen, Inc. | 2011-09-01 |
| Comparison of Markers of Kidney Function (NCT01403766) | University of California, Los Angeles | 2011-08-01 |
| Dexpramipexole Renal PK Study (NCT01424176) | Knopp Biosciences | 2011-07-01 |
| Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration (NCT01467271) | Guerbet | 2011-05-01 |
| Pharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes) (NCT01323075) | Centre Hospitalier Universitaire de Nīmes | 2011-05-01 |
| Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen (NCT01560572) | University Medical Center Groningen | 2011-04-01 |
| De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction (NCT01312064) | National Taiwan University Hospital | 2011-04-01 |
| A Study of Erythromycin and Rivaroxaban in Study Participants With Normal and Reduced Kidney Function (NCT01309438) | Janssen Research & Development, LLC | 2011-02-01 |
| Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment (NCT01316055) | Acorda Therapeutics | 2011-01-01 |
| Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency (NCT01172431) | West China Hospital | 2010-09-01 |
| Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal Impairment (NCT01164501) | Boehringer Ingelheim | 2010-07-01 |
| Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency (NCT01101087) | Centre Hospitalier Universitaire de Nīmes | 2010-07-01 |
| An Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment (NCT01064414) | Janssen Research & Development, LLC | 2010-06-01 |
| Study of an Intervention to Improve Problem List Accuracy and Use (NCT01105923) | Brigham and Women's Hospital | 2010-05-01 |
| "Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction" (NCT01121770) | Duke University | 2010-05-01 |
| A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers (NCT01119781) | Biogen | 2010-05-01 |
| Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transplantation (NCT01289548) | Huazhong University of Science and Technology | 2010-05-01 |
| A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis (NCT01057407) | Astellas Pharma Inc | 2010-01-01 |
| Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients (NCT01232010) | Asan Medical Center | 2009-11-01 |
| A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis (NCT01017276) | Astellas Pharma Inc | 2009-11-01 |
| Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients (NCT01231997) | Asan Medical Center | 2009-11-01 |
| Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL) (NCT00936247) | B. Braun Melsungen AG | 2009-11-01 |
| Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure (NCT01028170) | Aspirus Heart and Vascular Institute-Research and Education | 2009-11-01 |
| Colour Coded Duplex Ultrasound of Native Arterio-venous Fistula for Haemodialysis With Venous Pressure Measurement Using Controlled Compression Ultrasound as a Predictor for Shunt Maturation in the Early Postoperative Phase (NCT01001000) | University of Zurich | 2009-10-01 |
| A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function (NCT01715259) | Cougar Biotechnology, Inc. | 2009-08-01 |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Family Members (NCT00994188) | Tokushukai Medical Group | 2009-07-01 |
| A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties (NCT00980317) | Tokushukai Medical Group | 2009-07-01 |
| Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis (NCT00892749) | Astellas Pharma Inc | 2009-05-01 |
| Pain Management After Cardiac Surgery - Opioids or NSAID (NCT02479165) | Aalborg University Hospital | 2009-05-01 |
| Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency (NCT00927602) | Università degli Studi dell'Insubria | 2009-04-01 |
| Risk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department Siriraj Hospital (NCT01373775) | Mahidol University | 2009-04-01 |
| Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency (NCT00745316) | Biogen | 2009-02-01 |
| Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection (NCT00811863) | Guerbet | 2009-02-01 |
| Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency (NCT00911625) | Loyola University | 2009-01-21 |
| Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure (NCT00806039) | Saint Louis VA Medical Center | 2008-12-01 |
| Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist (NCT00744939) | Bayer | 2008-11-01 |
| Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function (NCT00721734) | Amgen | 2008-11-01 |
| Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA) (NCT00773409) | Bracco Diagnostics, Inc | 2008-10-01 |
| Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) (NCT00770081) | Novartis | 2008-09-01 |
| Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension) (NCT00765830) | Novartis | 2008-09-01 |
| Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance (NCT01545531) | University of Washington | 2008-09-01 |
| A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function. (NCT00721422) | Pfizer | 2008-08-01 |
| Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects. (NCT00731523) | Novartis | 2008-07-01 |
| Behaviour and Cognitive Evaluation for Dialysis Elderly Patients (BCDE) (NCT00847275) | Nantes University Hospital | 2008-07-01 |
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function (NCT02191228) | Boehringer Ingelheim | 2008-04-01 |
| A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function (NCT01759576) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-03-01 |
| Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease (NCT00600834) | Bracco Diagnostics, Inc | 2008-02-01 |
| Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease (NCT00600951) | Bracco Diagnostics, Inc | 2008-01-01 |
| Renal Safety Evaluation After Dotarem®-Enhanced MRI (NCT00650845) | Guerbet | 2008-01-01 |
| Concentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney Dysfunction (NCT00575484) | Barnes-Jewish Hospital | 2007-11-01 |
| Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure (NCT00527059) | University of Roma La Sapienza | 2007-10-01 |
| Clinical Assessment of a New Catheter Surface Coating With Antimicrobial Properties (NCT00621712) | Vantive Health LLC | 2007-10-01 |
| A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function (NCT00501462) | GlaxoSmithKline | 2007-07-01 |
| Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC (NCT00338455) | Scios, Inc. | 2006-09-01 |
| Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia (NCT00358046) | Ilypsa | 2006-06-01 |
| HaemoDYNAMICs in Primary and Secondary Hypertension (NCT01742702) | Tampere University | 2006-05-25 |
| Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly (NCT00413088) | Rovi Pharmaceuticals Laboratories | 2006-03-01 |
| COOL RCN: Cooling to Prevent Radiocontrast Nephropathy (NCT00306306) | Radiant Medical | 2006-03-01 |
| Multiple Intervention and AUdit in Renal Diseases to Optimize Care (NCT00566033) | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | 2006-01-01 |
| Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function (NCT00264693) | Luzerner Kantonsspital | 2006-01-01 |
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment (NCT02182024) | Boehringer Ingelheim | 2005-04-01 |
| Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation (NCT00656266) | Baylor College of Medicine | 2004-11-01 |
| Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT) (NCT00138099) | Hamilton Health Sciences Corporation | 2004-07-01 |
| A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass (NCT00187330) | Sunnybrook Health Sciences Centre | 2004-03-01 |
| BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS) (NCT00186329) | Stanford University | 2004-03-01 |
| Effects of Creatine Supplementation on Renal Function (NCT00465140) | University of Sao Paulo | 2004-01-01 |
| Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants (NCT00580047) | University of Nebraska | 2003-12-01 |
| Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction (NCT00119691) | Brigham and Women's Hospital | 2003-04-01 |
| Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis (NCT01207297) | Zhejiang University | 2003-03-01 |
| A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008) (NCT00418366) | Merck Sharp & Dohme LLC | 2003-01-01 |
| Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine (NCT02184091) | Boehringer Ingelheim | 1999-01-01 |
| The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects (NCT02172339) | Boehringer Ingelheim | 1998-04-01 |
| EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV (NCT02699736) | Rigshospitalet, Denmark | 1994-01-01 |